MLL2 overexpression was significantly associated with poor recurrence-free survival in adenocarcinoma (p = 0.02; Figure 6E) but not in squamous cell carcinoma (p = 0.87). The gene discussed is KMT2B; the disease is squamous cell carcinoma.